COMPOSITIONS FOR THE TREATMENT OF EPARKINSON DISEASE CONTAINING A CB1 RECEIVER ANTAGONIST AND A PRODUCT THAT ACTIVATES THE DEPAMINERGIC NEUROTRANSMISSION IN THE BRAIN.

摘要

Association of one or more products that activate dopaminergic neurotransmission in the brain and of one or more azetidine derivatives chosen from the following compounds: N- {1- [bis- (4-chlorophenyl) methyl] azetidin-3-yl} - N-pyrid-3- yl-methylsulfonamide, N- {1- [bis- (4-chlorophenyl) methyl] azetidin-3-yl} -N- (3, 5- difluorophenyl) -methylsulfonamide its pharmaceutically acceptable salts